Neurology

Key drivers include Myostatin inhibitors and label expansions, despite impending Spinraza patent expirations

According to GlobalData, the number of diagnosed prevalent cases of Alzheimer’s disease across major markets in APAC is expected…

The neuro-rehabilitation center includes an end-effector based robotic solution

The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the…